Koninklijke Philips (PHG)
(Delayed Data from NYSE)
$30.27 USD
+0.19 (0.63%)
Updated Aug 27, 2024 04:00 PM ET
After-Market: $30.27 0.00 (0.00%) 5:40 PM ET
3-Hold of 5 3
A Value B Growth F Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$30.27 USD
+0.19 (0.63%)
Updated Aug 27, 2024 04:00 PM ET
After-Market: $30.27 0.00 (0.00%) 5:40 PM ET
3-Hold of 5 3
A Value B Growth F Momentum B VGM
Zacks News
Philips (PHG) Drives Health Care Prospects With New Solutions
by Zacks Equity Research
Philips (PHG) announces Philips Virtual Care Management solutions, which provide a comprehensive approach to telehealth for patients, providers and payers.
AtriCure (ATRC) Moves 7.5% Higher: Will This Strength Last?
by Zacks Equity Research
AtriCure (ATRC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Philips' (PHG) Q4 Earnings Down Y/Y, Supply Chain Issues Ease
by Zacks Equity Research
Koninklijke Philips' (PHG) Q4 top and bottom-line results reflect easing supply chain constraints.
Are Investors Undervaluing GN Store Nord (GNNDY) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Masimo (MASI) Expands Partnership with Philips for W1 Watch
by Zacks Equity Research
Masimo (MASI) and Royal Philips to create an open ecosystem of medical information using Masimo W1 watch and the latter???s patient monitoring ecosystem to improve home-care.
Philips (PHG) Showcases New AI-Based Solutions at the RSNA
by Zacks Equity Research
Koninklijke Philips (PHG) banks on its new AI solutions to address issues faced by Radiology experts in the healthcare industry and drive prospects.
Why Is Boston Scientific (BSX) Up 5.6% Since Last Earnings Report?
by Zacks Equity Research
Boston Scientific (BSX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Philips' (PHG) Q3 Earnings Down on Supply Chain Constraints
by Zacks Equity Research
Koninklijke Philips' (PHG) Q3 top and bottom-line results reflect the negative impact of supply chain constraints, COVID lockdowns in China and the Russia-Ukraine war.
Company News for Oct 13, 2022
by Zacks Equity Research
Companies In The News Are: PEP, WIT, PHG, INTC.
Philips (PHG) to Showcase New Innovations & Cardiac Solutions
by Zacks Equity Research
Philips (PHG) is launching cardiac solutions to further benefit from its tried-and-tested strategic operational decision to build new products to attract more customers.
Philips (PHG) Expands Partnership to Build Angio CT Solution
by Zacks Equity Research
Philips (PHG) is building the world's first spectral detector angio CT solution by forging an alliance with the Leiden University Medical Center.
Philips (PHG) Alerts Users of Health Hazards of Therapy Masks
by Zacks Equity Research
Philips (PHG) cautions customers against health hazards faced by the users of CPAP or Bi-Level PAP therapy masks with magnetic headgear.
Philips' (PHG) Q2 Earnings Down on Supply Chain Constraints
by Zacks Equity Research
Koninklijke Philips' (PHG) Q2 top and bottom-line results reflect the negative impact of supply chain constraints and COVID lockdowns in China.
Philips (PHG) Expands AI Portfolio With SmartSpeed Solution
by Zacks Equity Research
Koninklijke Philips (PHG) announces that its latest AI-powered MR acceleration software SmartSpeed will be showcased as part of the AI-powered precision diagnosis portfolio at ECR.
Philips' (PHG) Launches a Range of New Products at EuroPCR 2022
by Zacks Equity Research
Philips' (PHG) launches innovative new solutions to attract customers amid a global supply crunch and drive top-line growth.
Philips' (PHG) Q1 Earnings Down Y/Y on Supply Chain Constraints
by Zacks Equity Research
Koninklijke Philips' (PHG) Q1 top- and bottom-line results reflect negative impact of supply chain constraints and consequences of the Respironics field action.
Philips' (PHG) Innovative Product Suite to Cheer Investors
by Zacks Equity Research
Philips (PHG) launches two major cardiological innovations at ACC 2022, adding strength and depth to its existing healthcare portfolio.
Philips' (PHG) Lung Suite 3D Imaging Solution Gains Traction
by Zacks Equity Research
Philips' (PHG) innovative lung cancer diagnosis and treatment solution, Philips Lung Suite, is witnessing rapid adoption by clinical partners globally
Philips (PHG) Ties Up With Nuvo Group to Boost Maternal Care
by Zacks Equity Research
Philips (PHG) collaborates with Nuvo to develop maternity care services with digital solutions and eco-system building in rural areas
Philips' (PHG) Collaboration Live Gets Nod for Remote Diagnosis
by Zacks Equity Research
Koninklijke Philips' (PHG) Collaboration Live integrated tele-ultrasound receives the expanded U.S. Food & Drug Administration 510(k) clearance for remote diagnostic use on additional mobile platforms.
The Zacks Analyst Blog Highlights: Roche Holding, Pfizer, Baxter International, STMicro and Philips
by Zacks Equity Research
Roche Holding, Pfizer, Baxter International, STMicro and Philips are included in this analyst blog.
Company News for Jan 25, 2022
by Zacks Equity Research
Companies in The News Are: PHG,CBU,BOH,NWBI
Phillips (PHG) Blends 3D Mapping With Zenition, Aids Prospects
by Zacks Equity Research
Phillips (PHG) integrates AI and 3D mapping capabilities it its Mobile C-Arm System, Zenition, enhancing its diagnostic imaging portfolio.
Philips' (PHG) Q4 Earnings Hit By Supply-Chain Issues, Recall
by Zacks Equity Research
Philips (PHG) fourth-quarter and 2021 results suffer from supply-chain constraints and adverse impact of the Respironics recall.
New Strong Sell Stocks for January 7th
by Zacks Equity Research
APTV, PHG, and SNCY have been added to the Zacks Rank #5 (Strong Sell) List on January 7, 2022